Question · asked by 1 review
Systemic antifungal vs placebo/no treatment: Generic quality of life measures
- Population
- chronic rhinosinusitis
- Intervention
- Systemic antifungal
- Comparison
- placebo/no treatment
- Outcome
- Generic quality of life measures
The review found no eligible studies for this question.
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Systemic antifungal vs placebo/no treatment Generic health‐related quality of life · chronic rhinosinusitis The review found no eligible studies for this question. Topical and systemic antifungal therapy for chronic rhinosinusitis (2018) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Topical and systemic antifungal therapy for chronic rhinosinusitis 2018 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.